Koji Yoshinaga

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Two concepts on the immunological aspect of blastocyst implantation
    Koji Yoshinaga
    Reproductive Sciences Branch, NICHD, NIH, DHHS, Maryland 20892 7510, USA
    J Reprod Dev 58:196-203. 2012
  2. ncbi request reprint Review of factors essential for blastocyst implantation for their modulating effects on the maternal immune system
    Koji Yoshinaga
    Reproductive Sciences Branch, Center for Population Research, National Institute of Child Health and Human Development, NIH, DHHS, Bethesda, MD 20892 7510, USA
    Semin Cell Dev Biol 19:161-9. 2008
  3. doi request reprint Research on Blastocyst Implantation Essential Factors (BIEFs)
    Koji Yoshinaga
    Reproductive Sciences Branch, Center for Population Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS, MD 20892 7510, USA
    Am J Reprod Immunol 63:413-24. 2010
  4. ncbi request reprint Anti-tumor mechanism of Z-100, an immunomodulatory Arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, on pulmonary metastases of B16F10 melanoma: restoration of helper T cell responses via suppression of glucocorticoid-genesis
    Hideki Oka
    Central Research Laboratories, Zeria Pharmaceutical Co, Ltd, Saitama, Japan
    Microbiol Immunol 46:343-51. 2002
  5. ncbi request reprint Antimetastatic effect of an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, Z-100, through the production of interleukin-12
    Hideki Oka
    Central Research Laboratories, Zeria Pharmaceutical Co, Ltd, Ohsato gun, Saitama, Japan
    Biol Pharm Bull 26:1336-41. 2003
  6. ncbi request reprint Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, augments anti-tumor activities of X-ray irradiation against B16 melanoma in association with the improvement of type 1T cell responses
    Hideki Oka
    Central Research Laboratories, Zeria Pharmaceutical Co Ltd, 2512 1 Oshikiri, Kohnan machi, Ohsato gun, Saitama 360 0111, Japan
    Biol Pharm Bull 27:82-8. 2004

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Two concepts on the immunological aspect of blastocyst implantation
    Koji Yoshinaga
    Reproductive Sciences Branch, NICHD, NIH, DHHS, Maryland 20892 7510, USA
    J Reprod Dev 58:196-203. 2012
    ..Thus, clarification of the roles of BIEFs in both the physiological/endocrinological aspect as well as the immunological aspect is essential for understanding the biological process of implantation...
  2. ncbi request reprint Review of factors essential for blastocyst implantation for their modulating effects on the maternal immune system
    Koji Yoshinaga
    Reproductive Sciences Branch, Center for Population Research, National Institute of Child Health and Human Development, NIH, DHHS, Bethesda, MD 20892 7510, USA
    Semin Cell Dev Biol 19:161-9. 2008
    ..Since little is known as to the action of these molecules on the uterine lymphocytes, its clarification is imperative to the understanding of the process of blastocyst implantation...
  3. doi request reprint Research on Blastocyst Implantation Essential Factors (BIEFs)
    Koji Yoshinaga
    Reproductive Sciences Branch, Center for Population Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS, MD 20892 7510, USA
    Am J Reprod Immunol 63:413-24. 2010
    ..BIEFs regulate these cells to successfully maintain pregnancy...
  4. ncbi request reprint Anti-tumor mechanism of Z-100, an immunomodulatory Arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, on pulmonary metastases of B16F10 melanoma: restoration of helper T cell responses via suppression of glucocorticoid-genesis
    Hideki Oka
    Central Research Laboratories, Zeria Pharmaceutical Co, Ltd, Saitama, Japan
    Microbiol Immunol 46:343-51. 2002
    ..These results suggest that Z-100 restores the balance of Th1/Th2 cell responses via the suppression of glucocorticoid-genesis by Z-100-induced IFN-gamma. IFN-gamma acts as a key cytokine in anti-tumor activities of Z-100...
  5. ncbi request reprint Antimetastatic effect of an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, Z-100, through the production of interleukin-12
    Hideki Oka
    Central Research Laboratories, Zeria Pharmaceutical Co, Ltd, Ohsato gun, Saitama, Japan
    Biol Pharm Bull 26:1336-41. 2003
    ....
  6. ncbi request reprint Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, augments anti-tumor activities of X-ray irradiation against B16 melanoma in association with the improvement of type 1T cell responses
    Hideki Oka
    Central Research Laboratories, Zeria Pharmaceutical Co Ltd, 2512 1 Oshikiri, Kohnan machi, Ohsato gun, Saitama 360 0111, Japan
    Biol Pharm Bull 27:82-8. 2004
    ..Moreover, we demonstrated that the effects of Z-100 were expressed at least in part, by the improvement of the T cell responses from type 2-dominant to type 1-dominant via up-regulation of IL-12 production...